ex.VAT:
VAT:
inc.VAT:

Offer valid until January 1st, 2025
Monday, February 13, 2023News

Senevisium, Silab's latest anti-senescence active ingredient

Senevisium, le dernier actif  anti-sénescence de Silab

Senevisium is a natural anti-aging active ingredient obtained from Ginkgo biloba, capable of reactivating the natural elimination of senescent fibroblasts by the immune system. It acts transversally on the dermis and the epidermis for an anti-wrinkle action and a rapid radiance-boosting effect.

Reading time
~ 2 minutes

Senescence, a central factor of aging, is controlled by the immune system that effectively locates and eradicates senescent cells that are harmful to the cutaneous environment. Over time, however, some senescent fibroblasts implement immunoevasion strategies to avoid being eliminated.
Thanks to novel in vitro and in vivo modeling studies, Silab revealed the accentuation of the immunoevasion mechanism at the level of the skin after the age of 60, inducing profound changes (wrinkles, dull complexion, loss of elasticity and senescence spots).
Through its targeted action, Senevisium is able to restore the natural elimination of immunoevasive senescent fibroblasts by the immune system by circumventing their two immoevasion pathways.

Rapid anti-aging benefits for mature skin

By allowing deleterious immunoevasive senescent fibroblasts to be recognized again and eliminated, Senevisium protects the skin from their harmful effects on matrix synthesis and epidermal renewal.
Tested at 2% in Caucasian volunteers, it enables the skin to restore its density and elasticity. The stage of wrinkles is reduced and complexion radiance is enhanced. The volunteers themselves confirm these results since 100% of them find their skin firmer, and their complexion lighter and more uniform after 28 days of treatment.

A longevity concentrate from Ginkgo biloba

Silab was inspired …

This content is only available to subscribersPREMIUM, PRO, STARTUP and TPE

Already subscribed?Log in

Discover our subscriptions

Register now!

NewsOther articles